rs149235072

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_002185.5(IL7R):​c.153G>A​(p.Ser51Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0021 in 1,613,122 control chromosomes in the GnomAD database, including 69 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0013 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0022 ( 64 hom. )

Consequence

IL7R
NM_002185.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.129

Publications

3 publications found
Variant links:
Genes affected
IL7R (HGNC:6024): (interleukin 7 receptor) The protein encoded by this gene is a receptor for interleukin 7 (IL7). The function of this receptor requires the interleukin 2 receptor, gamma chain (IL2RG), which is a common gamma chain shared by the receptors of various cytokines, including interleukins 2, 4, 7, 9, and 15. This protein has been shown to play a critical role in V(D)J recombination during lymphocyte development. Defects in this gene may be associated with severe combined immunodeficiency (SCID). Alternatively spliced transcript variants have been found. [provided by RefSeq, Dec 2015]
IL7R Gene-Disease associations (from GenCC):
  • immunodeficiency 104
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
  • Omenn syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 5-35860922-G-A is Benign according to our data. Variant chr5-35860922-G-A is described in ClinVar as Benign. ClinVar VariationId is 353261.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.129 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00135 (205/152240) while in subpopulation SAS AF = 0.0327 (158/4826). AF 95% confidence interval is 0.0286. There are 5 homozygotes in GnomAd4. There are 143 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL7RNM_002185.5 linkc.153G>A p.Ser51Ser synonymous_variant Exon 2 of 8 ENST00000303115.8 NP_002176.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL7RENST00000303115.8 linkc.153G>A p.Ser51Ser synonymous_variant Exon 2 of 8 1 NM_002185.5 ENSP00000306157.3

Frequencies

GnomAD3 genomes
AF:
0.00133
AC:
202
AN:
152122
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000524
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.0323
Gnomad FIN
AF:
0.000189
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000412
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00385
AC:
968
AN:
251152
AF XY:
0.00521
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.0000579
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000381
Gnomad FIN exome
AF:
0.0000924
Gnomad NFE exome
AF:
0.000335
Gnomad OTH exome
AF:
0.00147
GnomAD4 exome
AF:
0.00217
AC:
3177
AN:
1460882
Hom.:
64
Cov.:
30
AF XY:
0.00294
AC XY:
2140
AN XY:
726840
show subpopulations
African (AFR)
AF:
0.000688
AC:
23
AN:
33440
American (AMR)
AF:
0.000112
AC:
5
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26110
East Asian (EAS)
AF:
0.000327
AC:
13
AN:
39696
South Asian (SAS)
AF:
0.0285
AC:
2462
AN:
86240
European-Finnish (FIN)
AF:
0.0000374
AC:
2
AN:
53418
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5762
European-Non Finnish (NFE)
AF:
0.000464
AC:
516
AN:
1111136
Other (OTH)
AF:
0.00247
AC:
149
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
184
368
553
737
921
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00135
AC:
205
AN:
152240
Hom.:
5
Cov.:
32
AF XY:
0.00192
AC XY:
143
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.000144
AC:
6
AN:
41536
American (AMR)
AF:
0.000523
AC:
8
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.000580
AC:
3
AN:
5176
South Asian (SAS)
AF:
0.0327
AC:
158
AN:
4826
European-Finnish (FIN)
AF:
0.000189
AC:
2
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000412
AC:
28
AN:
68022
Other (OTH)
AF:
0.00
AC:
0
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
11
21
32
42
53
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000376
Hom.:
0
Bravo
AF:
0.000536
Asia WGS
AF:
0.0120
AC:
42
AN:
3478
EpiCase
AF:
0.000436
EpiControl
AF:
0.000474

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Immunodeficiency 104 Benign:2
Jan 21, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
15
DANN
Benign
0.45
PhyloP100
-0.13
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149235072; hg19: chr5-35861024; COSMIC: COSV57409062; API